, L., Preprint, July 7, 2020 (Preprint) (Review) (not included in the study count)
Hydroxych loroquine-based COVID-19 Treatment, A Systematic Review of Clinical Evidence and Expert Opinion from Physicians’ Surveys
85% of globally surveyed physicians recognized HC
Q as at least partially effective in treating COVID-19, according to Sermo W3. More than half of the surveyed US physicians would take the drug or give it to family members early or even before onset of symptoms, according to JC.
Aside from the rarely used plasma, HC
Q / HC
Q+AZ based treatments are preferred by physicians by wide margin over other drugs. HC
Q / HC
Q+AZ based treatments are the most used, most recommended, and most highly rated by physicians treating COVID-19 at an early stage.
Please send us corrections, updates, or comments.